B
ABBV icon

Brightworth’s AbbVie ABBV Stock Holding History

Brightworth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$283K Buy
2,109
+261
+14% +$37.5K 0.03% 112
2022
Q2 		$283K Buy
1,848
+224
+14% +$34.2K 0.03% 112
2022
Q1 		$263K Sell
1,624
-45
-3% -$6.54K 0.03% 113
2021
Q4 		$226K Buy
+1,669
New +$197K 0.02% 120
2018
Q4 		– Sell
-2,479
Closed -$234K – 92
2018
Q3 		$234K Buy
2,479
+139
+6% +$13.2K 0.05% 86
2018
Q2 		$217K Sell
2,340
-260
-10% -$25.4K 0.05% 86
2018
Q1 		$246K Buy
+2,600
New +$286K 0.06% 101

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brightworth's ABBV Position: Q3 2022 in Review

Brightworth increased its AbbVie (ABBV) stake by 14% in Q3 2022, buying an estimated $37.5K and bringing the position to 2,109 shares worth $283K. The position accounts for 0.03% of the portfolio, ranked #112.

Brightworth first reported a position in ABBV in Q1 2018 and has held it in 7 quarters since. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Brightworth held 2,109 shares of AbbVie worth $283K as of Q3 2022.
  • Brightworth bought 261 AbbVie shares in Q3 2022, an estimated $37.5K.
  • AbbVie made up 0.03% of Brightworth's portfolio in Q3 2022, its #112 holding.
  • Brightworth first reported a position in AbbVie in Q1 2018 and has held it in 7 quarters since.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Brightworth's 13F filing for Q3 2022, filed 28 Oct 2022.